CoreCap Advisors’s Catalyst Pharmaceutical CPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $594K | Sell |
27,381
-6,861
| -20% | -$149K | 0.02% | 472 |
|
|
2025
Q1 | $830K | Sell |
34,242
-1,638
| -5% | -$39.7K | 0.04% | 371 |
|
|
2024
Q4 | $749K | Buy |
35,880
+35,480
| +8,870% | +$740K | 0.03% | 382 |
|
|
2024
Q3 | $7.95K | Hold |
400
| – | – | ﹤0.01% | 1858 |
|
|
2024
Q2 | $6.2K | Sell |
400
-300
| -43% | -$4.65K | ﹤0.01% | 1138 |
|
|
2024
Q1 | $11.2K | Buy |
+700
| New | +$11.2K | ﹤0.01% | 1707 |
|
|
2023
Q3 | – | Sell |
-14,913
| Closed | -$200K | – | 564 |
|
|
2023
Q2 | $200K | Buy |
+14,913
| New | +$200K | 0.01% | 536 |
|
|
2022
Q4 | $160K | Buy |
+8,612
| New | +$160K | 0.01% | 588 |
|
|
2022
Q1 | – | Sell |
-6,000
| Closed | -$41K | – | 850 |
|
|
2021
Q4 | $41K | Buy |
+6,000
| New | +$41K | ﹤0.01% | 1064 |
|